An Innovative Collaboration Dedicated to Navigating the Complexities of Scientific Advancement from Concept to Commercialization
An Innovative Collaboration Dedicated to Navigating the Complexities of Scientific Advancement from Concept to Commercialization
In November 2017, Deerfield Management and Johns Hopkins University announced the creation of Bluefield Innovations, a collaboration designed to catalyze the development of early stage therapeutics. Funded by Deerfield, an investment management firm committed to advancing healthcare, Bluefield Innovations will provide up to $65 million in initial funding over five years to support the commercialization of early stage therapeutic research at Johns Hopkins, with additional funding available to advance research showing strong commercial potential.
A joint steering committee will identify the research that Bluefield will support through the preclinical development process — including basic research, proof of concept, target selection and investigational new drug (IND) enabling studies designed to qualify a candidate to enter into human clinical trials.
Combining the respective strengths of each organization — Johns Hopkins’ scientific discovery expertise and Deerfield’s drug development, operational and financial support — enables Bluefield to reduce the financial and developmental risk associated with early stage novel projects.
The Johns Hopkins University is America’s first research university, founded on the principle that by pursuing big ideas and sharing what we learn, we can make the world a better place. For more than 140 years, our faculty and students have worked side by side in pursuit of discoveries that improve lives. For more information, visit www.JHU.edu
Deerfield is an investment management firm committed to advancing healthcare through investment, information and philanthropy. For more information, please visit www.deerfield.com
